TAK logo

TAK Selling, general & administrative expenses

annual SGA:

$7.25B-$40.98M(-0.56%)
March 1, 2025

Summary

  • As of today (September 17, 2025), TAK annual SGA is $7.25 billion, with the most recent change of -$40.98 million (-0.56%) on March 1, 2025.
  • During the last 3 years, TAK annual SGA has fallen by -$640.97 million (-8.13%).
  • TAK annual SGA is now -18.33% below its all-time high of $8.87 billion, reached on March 31, 2020.

Performance

1-year change

-0.56%

3-year change

-8.13%

5-year change

-18.33%

15-year change

+27.87%

TAK SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.59%
TAK annual SGA is higher than 99.59% of companies in Healthcare sector

Range

All-time high

$8.87B
TAK annual SGA is currently -18.33% below its historical high of $8.87 billion

3-year low

$7.25B
TAK annual SGA is currently at its 3-year low

Earnings dates

Last annual earnings report date

Mar 1, 2025
TAK previous annual earnings announcement was published on Mar 1, 2025

Next annual earnings report date

N/A
TAK next annual earnings announcement has not yet been scheduled

OtherTAKincome statement metrics

Annual total expenses

$29.34B
TAK annual total expenses is $29.34 billion

annual operating expenses

$11.99B
TAK annual total operating expenses is $11.99 billion

annual cost of goods sold

$13.95B
TAK annual cost of goods sold is $13.95 billion

annual interest expense

$0.00
TAK annual interest expense is $0.00

quarterly SGA:

$0.00-$1.94B(-100.00%)
June 1, 2025

Summary

  • As of today (September 17, 2025), TAK quarterly SGA is $0.00, with the most recent change of -$1.94 billion (-100.00%) on June 1, 2025.
  • Over the past year, TAK quarterly SGA has dropped by -$1.73 billion (-100.00%).
  • TAK quarterly SGA is now -100.00% below its all-time high of $3.19 billion, reached on March 31, 2012.

Performance

3-month change

-100%

1-year change

-100%

3-year change

-100%

5-year change

-100%

TAK quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

70.08%
TAK quarterly SGA is higher than 70.08% of companies in Healthcare sector

Range

All-time high

$3.19B
TAK quarterly SGA is currently -100.00% below its historical high of $3.19 billion

3-year low

$0.00
TAK quarterly SGA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 1, 2025
TAK previous earnings announcement was published on Jun 1, 2025

Next quarterly earnings report date

Oct 30, 2025
TAK next earnings announcement is scheduled for Oct 30, 2025

OtherTAKincome statement metrics

Quarterly total expenses

$6.80B
TAK quarterly total expenses is $6.80 billion

quarterly operating expenses

$2.77B
TAK quarterly total operating expenses is $2.77 billion

quarterly cost of goods sold

$3.57B
TAK quarterly cost of goods sold is $3.57 billion

quarterly interest expense

$0.00
TAK quarterly interest expense is $0.00

TTM SGA:

$34.17B-$311.15M(-0.90%)
June 1, 2025

Summary

  • As of today (September 17, 2025), TAK TTM SGA is $34.17 billion, with the most recent change of -$311.15 million (-0.90%) on June 1, 2025.
  • Over the past year, TAK TTM SGA has increased by +$26.96 billion (+373.79%).
  • TAK TTM SGA is now -70.52% below its all-time high of $115.93 billion.

Performance

3-month change

+524.51%

1-year change

+373.79%

3-year change

+346.03%

5-year change

+298.42%

TAK TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97%
TAK TTM SGA is higher than 97% of companies in Healthcare sector

Range

All-time high

$115.93B
TAK TTM SGA is currently -70.52% below its historical high of $115.93 billion

3-year low

$34.17B
TAK TTM SGA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 1, 2025
TAK previous earnings announcement was published on Jun 1, 2025

Next quarterly earnings report date

Oct 30, 2025
TAK next earnings announcement is scheduled for Oct 30, 2025

OtherTAKincome statement metrics

Annual total expenses

$29.34B
TAK annual total expenses is $29.34 billion

annual operating expenses

$11.99B
TAK annual total operating expenses is $11.99 billion

TTM cost of goods sold

$14.14B
TAK TTM cost of goods sold is $14.14 billion

TTM interest expense

$0.00
TAK TTM interest expense is $0.00

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

annual SGA

$7.25B
TAK annual SGA is $7.25 billion

annual operating expenses

$11.99B
TAK annual total operating expenses is $11.99 billion

annual cost of goods sold

$13.95B
TAK annual cost of goods sold is $13.95 billion

TAK Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.6%-100.0%+373.8%
3 y3 years-8.1%-100.0%+346.0%
5 y5 years-18.3%-100.0%+298.4%

TAK Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.1%at low-100.0%at low-31.1%at low
5 y5-year-18.3%at low-100.0%at low-36.5%at low
alltimeall time-18.3%+662.9%-100.0%at low-70.5%+99.2%

TAK Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$3.74B(-31.7%)
Mar 2025
$7.25B(-0.6%)
$1.94B(>+9900.0%)
$5.47B(+0.4%)
Dec 2024
-
$0.00(-100.0%)
$5.45B(-24.9%)
Sep 2024
-
$1.80B(+3.7%)
$7.26B(+0.7%)
Jun 2024
-
$1.73B(-9.8%)
$7.21B(-1.0%)
Mar 2024
$7.29B(-1.0%)
$1.92B(+6.2%)
$7.28B(-0.0%)
Dec 2023
-
$1.81B(+3.4%)
$7.29B(-0.6%)
Sep 2023
-
$1.75B(-3.0%)
$7.33B(-0.7%)
Jun 2023
-
$1.80B(-6.3%)
$7.38B(+0.3%)
Mar 2023
$7.36B(-6.7%)
$1.92B(+3.8%)
$7.36B(+0.0%)
Dec 2022
-
$1.85B(+3.2%)
$7.36B(-2.4%)
Sep 2022
-
$1.80B(+0.9%)
$7.53B(-1.7%)
Jun 2022
-
$1.78B(-7.2%)
$7.66B(-2.9%)
Mar 2022
$7.89B(-4.5%)
$1.92B(-5.5%)
$7.89B(-3.5%)
Dec 2021
-
$2.03B(+5.5%)
$8.18B(-1.2%)
Sep 2021
-
$1.93B(-4.2%)
$8.28B(-1.3%)
Jun 2021
-
$2.01B(-9.0%)
$8.39B(+1.5%)
Mar 2021
$8.26B(-6.9%)
$2.21B(+3.7%)
$8.26B(-1.4%)
Dec 2020
-
$2.13B(+4.6%)
$8.37B(-1.9%)
Sep 2020
-
$2.04B(+8.3%)
$8.53B(-0.5%)
Jun 2020
-
$1.88B(-19.0%)
$8.58B(-3.3%)
Mar 2020
$8.87B(+37.1%)
$2.32B(+1.3%)
$8.87B(-1.4%)
Dec 2019
-
$2.29B(+10.2%)
$9.00B(+11.5%)
Sep 2019
-
$2.08B(-4.4%)
$8.07B(+10.2%)
Jun 2019
-
$2.18B(-11.2%)
$7.33B(+13.1%)
Mar 2019
$6.47B(+14.2%)
$2.45B(+79.6%)
$6.48B(+15.4%)
Dec 2018
-
$1.36B(+2.3%)
$5.61B(-0.8%)
Sep 2018
-
$1.33B(+0.4%)
$5.66B(-0.5%)
Jun 2018
-
$1.33B(-16.2%)
$5.69B(+0.3%)
Mar 2018
$5.67B(-0.9%)
$1.59B(+12.6%)
$5.67B(+0.1%)
Dec 2017
-
$1.41B(+3.3%)
$5.67B(+1.0%)
Sep 2017
-
$1.36B(+4.0%)
$5.61B(-1.1%)
Jun 2017
-
$1.31B(-17.1%)
$5.68B(-0.5%)
Mar 2017
$5.72B(+5.5%)
$1.58B(+16.7%)
$5.71B(+1.1%)
Dec 2016
-
$1.36B(-5.0%)
$5.65B(+0.4%)
Sep 2016
-
$1.43B(+6.2%)
$5.63B(+3.4%)
Jun 2016
-
$1.34B(-11.7%)
$5.44B(+0.2%)
Mar 2016
$5.42B(-2.8%)
$1.52B(+14.0%)
$5.43B(+1.1%)
Dec 2015
-
$1.33B(+7.4%)
$5.37B(-0.4%)
Sep 2015
-
$1.24B(-6.7%)
$5.39B(-3.0%)
Jun 2015
-
$1.33B(-9.1%)
$5.56B(-0.1%)
Mar 2015
$5.58B(+0.4%)
$1.46B(+8.2%)
$5.57B(-19.5%)
Dec 2014
-
$1.35B(-4.0%)
$6.91B(-15.3%)
Sep 2014
-
$1.41B(+5.4%)
$8.16B(-12.0%)
Jun 2014
-
$1.34B(-52.4%)
$9.27B(-11.2%)
Mar 2014
$5.55B(+32.0%)
$2.81B(+8.1%)
$10.44B(-2.6%)
Dec 2013
-
$2.60B(+3.1%)
$10.73B(-3.2%)
Sep 2013
-
$2.52B(+0.7%)
$11.08B(-3.5%)
Jun 2013
-
$2.51B(-19.0%)
$11.48B(-3.3%)
Mar 2013
$4.21B
$3.09B(+4.8%)
$11.87B(-0.8%)
Dec 2012
-
$2.95B(+1.0%)
$11.97B(+0.3%)
DateAnnualQuarterlyTTM
Sep 2012
-
$2.92B(+0.7%)
$11.94B(+6.6%)
Jun 2012
-
$2.90B(-9.0%)
$11.20B(+8.9%)
Mar 2012
$8.51B(+20.3%)
$3.19B(+9.3%)
$10.28B(+9.4%)
Dec 2011
-
$2.92B(+33.5%)
$9.40B(+15.0%)
Sep 2011
-
$2.19B(+10.0%)
$8.17B(+7.8%)
Jun 2011
-
$1.99B(-13.9%)
$7.59B(+1.0%)
Mar 2011
$7.07B(-6.1%)
$2.31B(+36.5%)
$7.51B(+44.4%)
Dec 2010
-
$1.69B(+5.9%)
$5.20B(+9.6%)
Sep 2010
-
$1.60B(-16.5%)
$4.74B(-8.5%)
Jun 2010
-
$1.91B(>+9900.0%)
$5.18B(+0.8%)
Mar 2010
$7.53B(-13.5%)
$0.00(-100.0%)
$5.14B(0.0%)
Dec 2009
-
$1.23B(-39.4%)
$5.14B(+31.6%)
Sep 2009
-
$2.04B(+8.9%)
$3.91B(+108.9%)
Jun 2009
-
$1.87B(>+9900.0%)
$1.87B(>+9900.0%)
Mar 2009
$8.71B(+69.5%)
$0.00(0.0%)
$0.00(0.0%)
Dec 2008
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2008
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2008
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2008
$5.14B(+23.5%)
-
-
Mar 2008
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2007
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2007
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2007
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2007
$4.16B(+1.5%)
-
-
Mar 2007
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2006
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
$4.10B(+97.7%)
-
-
Mar 2006
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2005
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2005
$2.07B(+7.6%)
-
-
Mar 2005
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2004
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2004
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2004
-
$0.00
$0.00
Mar 2004
$1.93B(-31.0%)
-
-
Mar 2003
$2.79B(+16.1%)
-
-
Mar 2002
$2.41B(-12.5%)
-
-
Mar 2001
$2.75B(+87.8%)
-
-
Mar 2000
$1.46B(+54.1%)
-
-
Mar 1999
$949.92M(-59.1%)
-
-
Mar 1998
$2.32B(-0.1%)
-
-
Mar 1997
$2.32B(-12.2%)
-
-
Mar 1996
$2.65B(+4.9%)
-
-
Mar 1995
$2.52B(+20.4%)
-
-
Mar 1994
$2.10B(+18.0%)
-
-
Mar 1993
$1.78B(+0.4%)
-
-
Mar 1992
$1.77B(+12.7%)
-
-
Mar 1991
$1.57B
-
-

FAQ

  • What is Takeda Pharmaceutical Company Limited annual SGA?
  • What is the all time high annual SGA for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited annual SGA year-on-year change?
  • What is Takeda Pharmaceutical Company Limited quarterly SGA?
  • What is the all time high quarterly SGA for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited quarterly SGA year-on-year change?
  • What is Takeda Pharmaceutical Company Limited TTM SGA?
  • What is the all time high TTM SGA for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited TTM SGA year-on-year change?

What is Takeda Pharmaceutical Company Limited annual SGA?

The current annual SGA of TAK is $7.25B

What is the all time high annual SGA for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high annual SGA is $8.87B

What is Takeda Pharmaceutical Company Limited annual SGA year-on-year change?

Over the past year, TAK annual SGA has changed by -$40.98M (-0.56%)

What is Takeda Pharmaceutical Company Limited quarterly SGA?

The current quarterly SGA of TAK is $0.00

What is the all time high quarterly SGA for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high quarterly SGA is $3.19B

What is Takeda Pharmaceutical Company Limited quarterly SGA year-on-year change?

Over the past year, TAK quarterly SGA has changed by -$1.73B (-100.00%)

What is Takeda Pharmaceutical Company Limited TTM SGA?

The current TTM SGA of TAK is $34.17B

What is the all time high TTM SGA for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high TTM SGA is $115.93B

What is Takeda Pharmaceutical Company Limited TTM SGA year-on-year change?

Over the past year, TAK TTM SGA has changed by +$26.96B (+373.79%)
On this page